35 36 Clinical Trial Registration: clinicaltrials.gov Identifier: NCT01103921 37 38 Precis: Consumption of HFCS-sweetened beverages for 2 weeks at 25%E increased risk factors for 39 cardiovascular disease comparably to fructose and more than glucose in young adults. 40 41 Word Count: 3600 42 43 44 45 46 47 48 49 Abstract: 50 Context: The American Heart Association Nutrition Committee recommends women and men consume 51 no more than 100 and 150 kcal of added sugar/day, respectively, whereas the Dietary Guidelines for 52 Americans, 2010 suggests a maximal added sugar intake of 25% or less of total energy. 53 Objective: To address this discrepancy, we compared the effects of consuming glucose, fructose or 54 high fructose corn syrup (HFCS) at 25% of energy requirements (E) on risk factors for cardiovascular 55 disease. 56 Participants, Design and Setting, Intervention: 48 adults (Age:18-40 years; BMI:18-35 kg/m 2 ) resided 57 at the Clinical Research Center for 3.5 days of baseline testing while consuming energy-balanced diets 58 containing 55%E complex carbohydrate. For 12 outpatient days they consumed usual ad libitum diets 59 along with 3 servings/day of glucose, fructose, or HFCS-sweetened beverages (n=16/group), which 60 provided 25%E requirements. Subjects then consumed energy-balanced diets containing 25%E sugar-61 sweetened beverages/30%E complex carbohydrate during 3.5 days of inpatient intervention testing. 62 Main Outcome Measures: 24-h TG AUC, fasting plasma LDL and apolipoprotein B (apoB) 63 concentrations. 64 Results: 24-h TG AUC was increased compared with baseline during consumption of fructose (+4.7±1.2 65 mmol/Lx24h, P=0.0032) and HFCS (+1.8±1.4 mmol/Lx24h, P=0.035), but not glucose (-1.9±0.9 66 mmol/Lx24h, P=0.14). Fasting LDL and apoB concentrations were increased during consumption of 67 fructose (LDL:+0.29±0.082 mmol/L, P=0.0023; apoB:+0.093± 0.022 g/L, P=0.0005) and HFCS 68 (LDL:+0.42±0.11 mmol/L, P<0.0001; apoB:+0.12±0.031 g/L, P<0.0001), but not glucose 69 (LDL:+0.012±0.071 mmol/L, P=0.86; apoB:+0.0097±0.019 g/L, P=0.91).
3 Introduction: In epidemiological studies, consumption of sugar and/or sugar-sweetened beverages has 76 been linked to the presence of unfavorable lipid levels (1-5), insulin resistance (6, 7), fatty liver (8, 9) , 77 type 2 diabetes (10-12), cardiovascular disease (13) and metabolic syndrome (14) . We have recently 78 reported that consumption of fructose-sweetened beverages at 25% of energy requirements (E) increased 79 visceral adipose deposition and de novo lipogenesis, produced dyslipidemia, and decreased glucose 80 tolerance/insulin sensitivity in older, overweight/obese men and women, while consumption of glucose-81 sweetened beverages did not (15) . Since the commonly consumed sugars, sucrose and high fructose corn 82 syrup (HFCS), are composed of 50-55% fructose, these results provide a potential mechanistic 83 explanation for the associations between sugar consumption and metabolic disease. However, the adverse 84 metabolic effects of fructose consumption observed in the older, overweight/obese population (15) may 85 not occur in a younger, leaner population. Authors of 3 recent reviews have concluded that long-term 86 sugar intakes as high as 25-50%E have no adverse effects with respect to components of metabolic 87 syndrome (16) and that fructose consumption up to 140 grams/day does not result in biologically relevant 88 increases of fasting or postprandial triglycerides (TG) in healthy, normal weight (17) or overweight or 89 obese (18) humans. These reviews (16, 17) are cited in the Report of the Dietary Guidelines Advisory 90 Committee on the Dietary Guidelines for Americans 2010, released June of 2010, in which a maximal 91 intake level of 25% or less of total energy from added sugars is suggested (19) . However, in August of 92 2009, the American Heart Association Nutrition Committee recommended that women consume no more 93 than 100 kcal/day and men consume no more than 150 kcal/day of added sugar (20) . This equates to 94 differences between the 2 guidelines of 400 kcal/d for women consuming 2000 kcal/d and 525 kcal/d for 95 men consuming 2500 kcal/d. To address this discrepancy, we compared the effects of consuming 25%E 96 as glucose, fructose or HFCS for 2 weeks on risk factors for cardiovascular disease in young adults.
98
Methods:
99
The subjects who participated in this study are a subgroup of participants from an ongoing 5-year NIH-100 funded investigation in which a total of 8 experimental groups (n=25/group) will be studied. The 101 5 objectives include comparing the metabolic effects of fructose, glucose, and HFCS consumption at 25%E, 102 and to compare the metabolic effects of fructose and HFCS consumption at 0%, 10%, 17.5% and 25%E.
103
The results reported in this paper are from the first 48 subjects to complete the study protocol in the 104 experimental groups consuming 25%E as glucose, fructose, or HFCS (n=16/group). Participants were 105 recruited through an internet listing (Craigslist.com) and underwent telephone and in-person interviews 106 with medical history, complete blood count, and serum biochemistry panel to assess eligibility. Inclusion 107 criteria included age 18-40 years and BMI 18-35 kg/m 2 with a self-report of stable body weight during the 108 prior six months. Exclusion criteria included: diabetes (fasting glucose >125 mg/dl), evidence of renal or 109 hepatic disease, fasting plasma TG >400 mg/dl, hypertension (>140/90 mm Hg), surgery for weight loss.
110
Individuals who smoked, habitually ingested more than two alcoholic beverages/day, exercised more than 111 3.5 hours/week at a level more vigorous than walking, or used thyroid, lipid-lowering, glucose-lowering, 112 anti-hypertensive, anti-depressant, or weight loss medications were also excluded. The UC Davis 113 Institutional Review Board approved the experimental protocol for this study, and subjects provided 114 written informed consent to participate.
116
For the 5 weeks prior to study, subjects were asked to limit daily consumption of sugar-containing 117 beverages to one 8-oz serving of fruit juice. Fifty-five subjects were enrolled in the experimental groups 118 consuming 25%E as glucose, fructose, or HFCS. Four subjects withdrew due to unwillingness to comply 119 with the study protocol (2 in the HFCS group, 2 prior to group assignment) and 2 were withdrawn due to 120 medical conditions not apparent during screening (HFCS and glucose group). The samples from one 121 subject (HFCS group) who completed the study protocol were not analyzed because of illness during the 122 24-h serial blood collection. The experimental groups were matched for gender (9 men, 7 women/group), This was a parallel-arm, diet intervention study with 3 phases: (1) a 3.5-day inpatient baseline period 127 during which subjects resided at the CCRC; (2) a 12-day outpatient intervention period; (3) a 3.5-day 128 inpatient intervention period at the CCRC. During days 2 and 3 of the baseline and intervention inpatient 129 periods, subjects consumed energy-balanced meals consisting of conventional foods. Daily energy 130 requirements were calculated by the Mifflin equation (21) beverages were provided to subjects as three daily servings consumed with meals, and were flavored with 136 an unsweetened drink mix (Kool-aid ® , Kraft). The timing of inpatient meal service and the energy 137 distribution were: Breakfast-09:00h (25%); Lunch-13:00h (35%); Dinner-18:00h (40%).
139
During the 12-day outpatient phase of the study, subjects were provided with and instructed to drink 3 140 servings of sugar-sweetened beverage/day (one/meal), to consume their usual diet, and to not consume 141 other sugar-containing beverages, including fruit juice. To monitor compliance, the sugar-sweetened 142 beverages contained a biomarker (riboflavin), which was measured fluorimetrically in urine samples 143 collected at the time of beverage-pickup. These measurements indicated that the 3 groups of subjects were 144 comparably compliant.
146
Twenty-four hour serial blood collections were conducted on the 3 rd day of the baseline (0 wk) and 147 intervention (2 wk) inpatient periods. Three fasting blood samples were collected at 08:00, 08:30, 09:00h.
148
Twenty-nine postprandial blood samples were collected at 30-60 minute intervals from 09:30 until 08:00h 149 the next morning. Additional 6 ml samples were collected at the fasting time-points, 08:00, 08:30, 150 09:00h, and also at 22:00, 23:00, 24:00h, the period during which TG concentrations peaked during our 7 previous study (15) . The additional plasma from the 3 fasting samples was pooled, as was that from the 3 152 late-evening postprandial samples; multiple aliquots of each pooled sample were stored at -80°C. 
170
The incremental 24-h area AUC was calculated for TG, glucose and insulin by the trapezoidal method.
171
Glucose and insulin post-meal peaks were assessed as the mean amplitudes of the three post-meal 172 peaks; specifically the peak post-meal value minus the pre-meal value was averaged for breakfast, 173 lunch and dinner for each subject. The absolute change (∆ from 2 wk when 25%E sugar/30%E 174 complex carbohydrate was consumed compared with 0 wk when 55%E complex carbohydrate was 175 consumed) for each outcome was analyzed with SAS 9.2 (SAS, Cary, NC) in a mixed procedures (PROC 176 MIXED) model with sugar and gender as factors, and BMI, the change (2 wk -0 wk) in body weight 8 (∆BW), and outcome concentration at baseline (outcome B ) as continuous covariables. ∆BW and 178 outcome B were removed if they did not improve the precision of the model. Significant differences (P < 179 0.05) among the three sugars were identified by the Tukey's multiple comparisons test. Outcomes that 180 were significantly affected by 2 weeks of glucose, fructose or HFCS consumption were identified as least 181 squares means (LS means) of the change significantly different than zero. Primary outcomes were also 182 analyzed with BMI as a factor (BMI <25 m/kg 2 vs >25 m/kg 2 ). Data are presented as mean ± SEM.
184
Results: There were no significant differences among the 3 experimental groups in anthropomorphic 185 (Table 1) or outcome measures at baseline (Tables 2,3,S1). Body weight ( Table 3 ) and blood pressure 186 (data not shown) were not affected by 2 weeks consumption of glucose, fructose or HFCS.
188
Primary outcomes -Comparing glucose, fructose and HFCS with complex carbohydrate 189 consumption: Table 2 presents 
253

Compared with baseline, the 24-h glucose and insulin 24-h AUCs and the post-meal insulin peaks
254 were significantly increased in subjects consuming glucose, significantly decreased in subjects 255 11 consuming fructose, and were unchanged in subjects consuming HFCS (Online Table S1 ). Post- (26) (27) (28) . It is important to note that for both the current and previous study (15), the differential effects of 282 fructose and HFCS compared to complex carbohydrate on the 24-h TG profile were most marked in the 283 late evening, approximately 4 and 6 hours after dinner. Studies investigating the relationship between this 284 late-evening peak and proatherogenic changes would be of interest, as would investigations into the 285 sources of the TG that contributes to these peaks (DNL, diet, or 
320
As would be expected based on the evidence that both increasing age and post-menopausal status result in 321 augmented postprandial lipid responses in women (35), more significant gender differences in lipid 322 outcomes were observed in these younger subjects in the current study than in the older subjects 323 previously studied (15). With the exception of postprandial TG, apoB and RLP-C and RLP-TG, younger 324 men exhibited larger lipoprotein responses after 2 weeks of sugar consumption than younger women. The 325 comparable responses in postprandial TG and apoB concentrations and the significantly different fasting 326 TG and apoB responses between the genders suggest that rates of VLDL secretion may be similar 327 between men and women, whereas rates of VLDL clearance are different. This is supported by kinetic 328 studies, which demonstrate that women have higher TG-rich lipoprotein and LDL-apoB fractional 329 catabolic rates than men, while production rates are comparable (36, 37).
331
The greater effect of glucose consumption on sdLDL-C levels in younger men compared with younger 332 women represents the most marked difference between the current and our previous lipid results, which 333 14 showed older men and women were comparably non-responsive to consumption of glucose (15). The 334 increase of fasting sdLDL-C concentrations compared with baseline in younger men consuming glucose 335 was unexpected, as they did not exhibit increases in fasting LDL and apoB concentrations.
337
The added sugar component of the typical US diet consists of nearly equal amounts of HFCS and sucrose 338 (38) , therefore it is a limitation of this study that we did not also investigate the effects of sucrose 339 consumption. However, we expect that the effects of sucrose would be comparable to those of HFCS 340 because its composition (50% glucose/50% fructose) is very similar to the composition of the HFCS used 341 for this study (45% glucose/55% fructose). This is supported by results from a crossover study in which 342 subjects consumed standardized diets containing 5, 18, or 33% of energy as sucrose, each for 6 weeks.
343
Compared with the 5% sucrose diet, LDL concentrations increased by 17% on the 18% sucrose diet and 344 by 22% on the 33% sucrose diet (39). 345 346 Self-reported intake data suggest that 13% of the US population consumes >25% of energy from added 347 sugar (40) . Importantly, the current results provide evidence that sugar consumption at this level increases 348 risk factors for cardiovascular disease within 2 weeks in young adults, thus providing direct experimental 349 support for the epidemiological evidence linking sugar consumption with dyslipidemia (1-5) and 350 cardiovascular disease (13). They contradict the conclusions from recent reviews that sugar intakes as 351 high as 25-50% of energy have no adverse long-term effects with respect to components of the metabolic Gender 0.34 BMI 0.61 1 PROC MIXED 2-factor (sugar, gender) analysis with adjustment for BMI, ∆BW (2wk -0wk) and outcome B on absolute ∆ (2wk vs 0wk) 2 PROC MIXED 2-factor (sugar, gender) analysis with adjustment for BMI on absolute ∆ (2wk vs 0wk) 3 PROC MIXED 2-factor (sugar, gender) analysis with adjustment for BMI and ∆BW (2wk -0wk) on absolute ∆ (2wk vs 0wk) *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 LS means of ∆ different from zero a ∆ (2wk vs 0wk) significantly different from b ∆ (2wk vs 0wk), Tukey's multiple comparison test P > 0.05 for differences among groups at baseline for all outcomes Mean ± SEM PP sdLDL-C 4 0.65±0.08 0.79±0.10** ,a 0.48±0.04 0.64±0.07**** ,ab 0.60±0.08 0.86±0.10**** ,b Sugar 0.019 (mmol/L) Gender <0.0001 BMI 0.0125 1 PROC MIXED 2-factor (sugar, gender) analysis with adjustment for BMI on absolute ∆ (2wk vs 0wk) 2 PROC MIXED 2-factor (sugar, gender) analysis with adjustment for BMI, ∆BW (2wk -0wk) and outcome B on absolute ∆ (2wk vs 0wk) 3 PROC MIXED 2-factor (sugar, gender) analysis with adjustment for BMI and outcome B on absolute ∆ (2wk vs 0wk) 4 PROC MIXED 2-factor (sugar, gender) analysis with adjustment for BMI and ∆BW (2wk -0wk) on absolute ∆ (2wk vs 0wk) *P < 0.05,**P < 0.01, ***P < 0.001, ****P < 0.0001 LS means of ∆ different from zero a ∆ (2wk vs 0wk) significantly different from b ∆ (2wk vs 0wk), Tukey's multiple comparison test P > 0.05 for differences among groups at baseline for all outcomes Mean ± SEM 
